CICERI, PAOLA
CICERI, PAOLA
Dipartimento di Scienze della Salute
Uremic Toxin‐Driven Vascular Calcification in Chronic Kidney Disease: Molecular Pathways and Integrated Phenotypes
2026 R. Fernando Rivera, M. Teresa Sciarrone Alibrandi, N. Edvige Foligno, L. Magagnoli, P. Ciceri, M. Cozzolino
How are developments in the treatment armamentarium of hyperphosphatemia addressing the current therapeutic challenges?
2026 L. Magagnoli, P. Ciceri, M. Cozzolino
Beyond Biochemical Control: Reconsidering the Skeletal Impact of Calcimimetics in Hemodialysis
2026 M. Cozzolino, P. Ciceri, L. Magagnoli
Vascular Calcification in Advanced Chronic Kidney Disease: Epidemiology, Pathophysiology, and Treatment
2026 R. Fernando Rivera, M. Teresa Sciarrone Alibrandi, N. Edvige Foligno, L. Magagnoli, P. Ciceri, M. Cozzolino
Endocrine and metabolic alterations in aging PLWH with low bone mineral density
2026 V. Bono, C. Tincati, M. Augello, R. Rovito, A. Previtera, V. Sala, F. Monti, M. Cozzolino, P. Ciceri, G. Marchetti
Apoptotic Bodies in Kidney Disease: Orchestrators of Inflammation, Fibrosis, and Repair
2026 M. Cozzolino, P. Ciceri
Hemoadsorption/hemodialysis: current evidence and outcome on uremic toxin removal and symptom improvement
2026 M. Cozzolino, L. Magagnoli, P. Ciceri
High glucose enhances inflammation-driven platelet adhesion to endothelial cells in vitro
2026 M. Scavone, A. Fioretti, M. Molinaro, C. Ghali, C. Martinelli, T. Mencarini, S. Bozzi, N. Santo, U. Gianelli, M. Miozzo, M. Guazzi, G.M. Podda, M. Cozzolino, P. Ciceri
RAASi, MRA and FGF-23 in CKD progression: the usual suspects?
2025 G. Cianciolo, M. Provenzano, L. Hu, S. Barbuto, M.J. Soler, P. Ciceri, M. Cozzolino, G. La Manna
MCO Membranes and FGF-23: Advancing Dialysis Strategies for Better Outcomes?
2025 S. Barbuto, L. Magagnoli, G. Cianciolo, G. La Manna, M. Cozzolino, P. Ciceri
From Physicochemical Classification to Multidimensional Insights: A Comprehensive Review of Uremic Toxin Research
2025 M. Cozzolino, L. Magagnoli, P. Ciceri
High-phosphate Causes Endothelial Extracellular Matrix Calcification by Inducing Endothelial Cell Mesenchymal Transition and Osteoblastic Differentiation
2025 P. Ciceri, L. Artioli, M. Molinaro, M. Falleni, D. Tosi, C. Martinelli, N. Santo, O. Rondinone, M. Miozzo, P. Bianchi, U. Gianelli, L. Fontana, M. Cozzolino
Critical evaluation of therapeutic targeting in chronic kidney disease: where do we stand 5 years on?
2025 M. Cozzolino, L. Magagnoli, P. Ciceri
Calcimimetics and vascular calcification
2025 A. Chandu, C. Arana, J. Daniel Díaz-García, M. Cozzolino, P. Ciceri, J. Torregrosa
Vitamin D: are all compounds equal?
2025 L. Magagnoli, M. Cassia, A. Galassi, P. Ciceri, E. Massò, R. Gelpi, J. Bover, M. Cozzolino
Kynurenine Promotes Phosphate-Induced Endothelial Calcification via Endothelial-to-Mesenchymal Transition, Osteoblastic Differentiation and AhR Activation
2025 M. Molinaro, M. Cozzolino, P. Ciceri
Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease—a comprehensive review from the ERA CKD-MBD working group
2024 M. Kanbay, S. Copur, L. Ozbek, A. Mutlu, D. Cejka, P. Ciceri, M. Cozzolino, M.L. Haarhaus
Patient-specific multifactorial mortality risk assessment using classification and regression tree analysis in the context of ambulatory blood pressure monitoring
2024 B.T. Çetin, N.B. Hasbal, E. Cevik, O.E. Sahin, M. Akyol, Z. Kalay, D. Ucku, C. Tanriover, M. Güldan, L. Özbek, O. Memetoglu, M.E. Erden, S. Copur, I. Siriopol, D. Siriopol, P. Ciceri, M. Cozzolino, M. Kanbay
Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, Current treatments and investigational drugs
2024 L. Magagnoli, P. Ciceri, M. Cozzolino
Angiopoietin as A Novel Prognostic Marker in Kidney Disease
2024 A.B. Yildiz, S. Copur, C. Tanriover, F. Yavuz, S. Vehbi, A. Gaipov, L. Magagnoli, P. Ciceri, M. Cozzolino, M. Kanbay